Prosemble is pleased to announce that its Chief Financial Officer and Chief Operating Officer, Inna Zhuranskaya, attended the World Finance Forum – London Autumn 2025 this week. During the event, Ms Zhuranskaya met with Bili Eseanobi, Associate Director of Commercial...

Inna Zhuranskaya recently attended the Twin Path Portfolio Day, an event bringing together leaders and innovators from across technology, healthcare, and venture capital. During the event, Inna met with James Rosenthal, Director, Global Strategic Initiatives, Google...

Prosemble is pleased to announce the commencement of the immunogenicity phase of its mouse trials, conducted in partnership with TransCure BioServices, following the successful completion of the safety stage. This new phase will assess immune responses in CD34+...

We are proud to announce that Iryna Peretiazhko, currently completing her PhD at the Francis Crick Institute and Imperial College London under the supervision of Prof. Peter Rosenthal (Crick) and Dr Beeby (Imperial College), has had her article published in Nature —...

Prosemble recently participated in a competition run by the Düsseldorf regional government and is proud to share that we’ve been selected as a MedX@Düsseldorf Winners 2025—securing a booth at MEDICA 2025 in the coveted Start-up Park. MEDICA is one of the world’s...

On 17th July, Prosemble was awarded an AWS grant to support the assessment and implementation of large language models (LLMs) within our AI technology stack. This marks an exciting step forward in the evolution of our platform, particularly in enhancing its...